These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

340 related articles for article (PubMed ID: 22106115)

  • 1. Patient preferences for psoriasis treatments: process characteristics can outweigh outcome attributes.
    Schaarschmidt ML; Schmieder A; Umar N; Terris D; Goebeler M; Goerdt S; Peitsch WK
    Arch Dermatol; 2011 Nov; 147(11):1285-94. PubMed ID: 22106115
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comorbidities significantly impact patients' preferences for psoriasis treatments.
    Schmieder A; Schaarschmidt ML; Umar N; Terris DD; Goebeler M; Goerdt S; Peitsch WK
    J Am Acad Dermatol; 2012 Sep; 67(3):363-72. PubMed ID: 22015150
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patient preferences for psoriasis treatments: impact of treatment experience.
    Schaarschmidt ML; Umar N; Schmieder A; Terris DD; Goebeler M; Goerdt S; Peitsch WK
    J Eur Acad Dermatol Venereol; 2013 Feb; 27(2):187-98. PubMed ID: 22225546
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patient Preferences for Treatment of Psoriasis with Biologicals: A Discrete Choice Experiment.
    Kromer C; Schaarschmidt ML; Schmieder A; Herr R; Goerdt S; Peitsch WK
    PLoS One; 2015; 10(6):e0129120. PubMed ID: 26058083
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patient preferences for psoriasis treatment: process characteristics considered more important than outcome attributes.
    Meredith F; Ormerod AD
    Expert Rev Pharmacoecon Outcomes Res; 2012 Apr; 12(2):145-7. PubMed ID: 22458615
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment preferences for biologicals in psoriasis: experienced patients appreciate sustainability.
    Kromer C; Peitsch WK; Herr R; Schmieder A; Sonntag D; Schaarschmidt ML
    J Dtsch Dermatol Ges; 2017 Feb; 15(2):189-200. PubMed ID: 28214326
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In the eye of the beholder: preferences of patients, family physicians, and surgeons for lumbar spinal surgery.
    Bederman SS; Mahomed NN; Kreder HJ; McIsaac WJ; Coyte PC; Wright JG
    Spine (Phila Pa 1976); 2010 Jan; 35(1):108-15. PubMed ID: 20042962
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Veterans' decision-making preferences and perceived involvement in care for chronic heart failure.
    Rodriguez KL; Appelt CJ; Switzer GE; Sonel AF; Arnold RM
    Heart Lung; 2008; 37(6):440-8. PubMed ID: 18992627
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Objective assessment of compliance with psoriasis treatment.
    Zaghloul SS; Goodfield MJ
    Arch Dermatol; 2004 Apr; 140(4):408-14. PubMed ID: 15096368
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Health-related quality of life in psoriasis: an analysis of Psocare project patients.
    Spandonaro F; Altomare G; Berardesca E; Calzavara-Pinton P; Chimenti S; Girolomoni G; Peserico A; Guerra AP; Vena GA; Polistena B; Ayala F
    G Ital Dermatol Venereol; 2011 Jun; 146(3):169-77. PubMed ID: 21566546
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patients with moderate-to-severe plaque psoriasis preferred oral therapies to phototherapies: a preference assessment based on clinical scenarios with trade-off questions.
    Opmeer BC; Heydendael VM; deBorgie CA; Spuls PI; Bossuyt PM; Bos JD; de Rie MA
    J Clin Epidemiol; 2007 Jul; 60(7):696-703. PubMed ID: 17573985
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patients' and Physicians' Preferences for Systemic Psoriasis Treatments: A Nationwide Comparative Discrete Choice Experiment (PsoCompare).
    Schaarschmidt ML; Herr R; Gutknecht M; Wroblewska K; Gerdes S; Sticherling M; Augustin M; Peitsch WK
    Acta Derm Venereol; 2018 Feb; 98(2):200-205. PubMed ID: 29110022
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patient Preferences for Biologicals in Psoriasis: Top Priority of Safety for Cardiovascular Patients.
    Schaarschmidt ML; Kromer C; Herr R; Schmieder A; Sonntag D; Goerdt S; Peitsch WK
    PLoS One; 2015; 10(12):e0144335. PubMed ID: 26633680
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of patient-reported outcomes in moderate to severe psoriasis.
    Krenzer S; Radtke M; Schmitt-Rau K; Augustin M
    Dermatology; 2011; 223(1):80-6. PubMed ID: 21876341
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patients' preferences for characteristics associated with treatments for osteoarthritis.
    Ratcliffe J; Buxton M; McGarry T; Sheldon R; Chancellor J
    Rheumatology (Oxford); 2004 Mar; 43(3):337-45. PubMed ID: 14585925
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcomes associated with matching patients' treatment preferences to physicians' recommendations: study methodology.
    Umar N; Litaker D; Schaarschmidt ML; Peitsch WK; Schmieder A; Terris DD
    BMC Health Serv Res; 2012 Jan; 12():1. PubMed ID: 22214259
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and tolerability of a cosmetically acceptable coal tar solution in the treatment of moderate plaque psoriasis: a controlled comparison with calcipotriene (calcipotriol) cream.
    Alora-Palli MB; Perkins AC; Van Cott A; Kimball AB
    Am J Clin Dermatol; 2010; 11(4):275-83. PubMed ID: 20513160
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Balancing the benefits and risks of drug treatment: a stated-preference, discrete choice experiment with patients with psoriasis.
    Seston EM; Ashcroft DM; Griffiths CE
    Arch Dermatol; 2007 Sep; 143(9):1175-9. PubMed ID: 17875880
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors that affect adherence to bipolar disorder treatments: a stated-preference approach.
    Johnson FR; Ozdemir S; Manjunath R; Hauber AB; Burch SP; Thompson TR
    Med Care; 2007 Jun; 45(6):545-52. PubMed ID: 17515782
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Costs and quality of life in patients with moderate to severe plaque-type psoriasis in Germany: a multi-center study.
    Schöffski O; Augustin M; Prinz J; Rauner K; Schubert E; Sohn S; Reich K
    J Dtsch Dermatol Ges; 2007 Mar; 5(3):209-18. PubMed ID: 17338796
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.